286 related articles for article (PubMed ID: 32821953)
1. The role of radiomics in prostate cancer radiotherapy.
Delgadillo R; Ford JC; Abramowitz MC; Dal Pra A; Pollack A; Stoyanova R
Strahlenther Onkol; 2020 Oct; 196(10):900-912. PubMed ID: 32821953
[TBL] [Abstract][Full Text] [Related]
2. Cone-beam computed tomography-based radiomics in prostate cancer: a mono-institutional study.
Bosetti DG; Ruinelli L; Piliero MA; van der Gaag LC; Pesce GA; Valli M; Bosetti M; Presilla S; Richetti A; Deantonio L
Strahlenther Onkol; 2020 Oct; 196(10):943-951. PubMed ID: 32875372
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy.
Yang F; Ford JC; Dogan N; Padgett KR; Breto AL; Abramowitz MC; Dal Pra A; Pollack A; Stoyanova R
Transl Androl Urol; 2018 Jun; 7(3):445-458. PubMed ID: 30050803
[TBL] [Abstract][Full Text] [Related]
4. Cone beam CT for QA of synthetic CT in MRI only for prostate patients.
Palmér E; Persson E; Ambolt P; Gustafsson C; Gunnlaugsson A; Olsson LE
J Appl Clin Med Phys; 2018 Nov; 19(6):44-52. PubMed ID: 30182461
[TBL] [Abstract][Full Text] [Related]
5. A feature alignment score for online cone-beam CT-based image-guided radiotherapy for prostate cancer.
Hargrave C; Deegan T; Poulsen M; Bednarz T; Harden F; Mengersen K
Med Phys; 2018 Jul; 45(7):2898-2911. PubMed ID: 29772077
[TBL] [Abstract][Full Text] [Related]
6. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
[TBL] [Abstract][Full Text] [Related]
7. Repeatability of Multiparametric Prostate MRI Radiomics Features.
Schwier M; van Griethuysen J; Vangel MG; Pieper S; Peled S; Tempany C; Aerts HJWL; Kikinis R; Fennessy FM; Fedorov A
Sci Rep; 2019 Jul; 9(1):9441. PubMed ID: 31263116
[TBL] [Abstract][Full Text] [Related]
8. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
[TBL] [Abstract][Full Text] [Related]
9. Cone-beam computed tomography-based delta-radiomics for early response assessment in radiotherapy for locally advanced lung cancer.
Shi L; Rong Y; Daly M; Dyer B; Benedict S; Qiu J; Yamamoto T
Phys Med Biol; 2020 Jan; 65(1):015009. PubMed ID: 31307024
[TBL] [Abstract][Full Text] [Related]
10. Radiomics Features Measured with Multiparametric Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness.
Hectors SJ; Cherny M; Yadav KK; Beksaç AT; Thulasidass H; Lewis S; Davicioni E; Wang P; Tewari AK; Taouli B
J Urol; 2019 Sep; 202(3):498-505. PubMed ID: 30958743
[TBL] [Abstract][Full Text] [Related]
11. Patient-specific deep learning model to enhance 4D-CBCT image for radiomics analysis.
Zhang Z; Huang M; Jiang Z; Chang Y; Lu K; Yin FF; Tran P; Wu D; Beltran C; Ren L
Phys Med Biol; 2022 Apr; 67(8):. PubMed ID: 35313293
[No Abstract] [Full Text] [Related]
12. Quantitative cone-beam CT imaging in radiation therapy using planning CT as a prior: first patient studies.
Niu T; Al-Basheer A; Zhu L
Med Phys; 2012 Apr; 39(4):1991-2000. PubMed ID: 22482620
[TBL] [Abstract][Full Text] [Related]
13. Assessment of CT to CBCT contour mapping for radiomic feature analysis in prostate cancer.
Schmidt RM; Delgadillo R; Ford JC; Padgett KR; Studenski M; Abramowitz MC; Spieler B; Xu Y; Yang F; Dogan N
Sci Rep; 2021 Nov; 11(1):22737. PubMed ID: 34815464
[TBL] [Abstract][Full Text] [Related]
14. Repeatability of CBCT radiomic features and their correlation with CT radiomic features for prostate cancer.
Delgadillo R; Spieler BO; Ford JC; Kwon D; Yang F; Studenski M; Padgett KR; Abramowitz MC; Dal Pra A; Stoyanova R; Pollack A; Dogan N
Med Phys; 2021 May; 48(5):2386-2399. PubMed ID: 33598943
[TBL] [Abstract][Full Text] [Related]
15. Are cone beam CT image matching skills transferrable from planning CT to planning MRI for MR-only prostate radiotherapy?
Brooks RL; McCallum HM; Pearson RA; Pilling K; Wyatt J
Br J Radiol; 2021 Jul; 94(1123):20210146. PubMed ID: 33914617
[TBL] [Abstract][Full Text] [Related]
16. Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.
Tamihardja J; Cirsi S; Kessler P; Razinskas G; Exner F; Richter A; Polat B; Flentje M
Radiat Oncol; 2021 Oct; 16(1):205. PubMed ID: 34702305
[TBL] [Abstract][Full Text] [Related]
17. Radiomics for liver tumours.
Dreher C; Linde P; Boda-Heggemann J; Baessler B
Strahlenther Onkol; 2020 Oct; 196(10):888-899. PubMed ID: 32296901
[TBL] [Abstract][Full Text] [Related]
18. Increasing the efficiency of cone-beam CT based delta-radiomics using automated contours to predict radiotherapy-related toxicities in prostate cancer.
Delgadillo R; Deana AM; Ford JC; Studenski MT; Padgett KR; Abramowitz MC; Pra AD; Spieler BO; Dogan N
Sci Rep; 2024 Apr; 14(1):9563. PubMed ID: 38671043
[TBL] [Abstract][Full Text] [Related]
19. A novel approach for establishing benchmark CBCT/CT deformable image registrations in prostate cancer radiotherapy.
Kim J; Kumar S; Liu C; Zhong H; Pradhan D; Shah M; Cattaneo R; Yechieli R; Robbins JR; Elshaikh MA; Chetty IJ
Phys Med Biol; 2013 Nov; 58(22):8077-97. PubMed ID: 24171908
[TBL] [Abstract][Full Text] [Related]
20. MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218).
Gugliandolo SG; Pepa M; Isaksson LJ; Marvaso G; Raimondi S; Botta F; Gandini S; Ciardo D; Volpe S; Riva G; Rojas DP; Zerini D; Pricolo P; Alessi S; Petralia G; Summers PE; Mistretta FA; Luzzago S; Cattani F; De Cobelli O; Cassano E; Cremonesi M; Bellomi M; Orecchia R; Jereczek-Fossa BA
Eur Radiol; 2021 Feb; 31(2):716-728. PubMed ID: 32852590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
